Success Metrics

Completion Rate
0%(0/3)
Active Trials
1(17%)
Terminated
3(50%)

Phase Distribution

Ph not_applicable
3
50%
Ph phase_1
1
17%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 3 finished

Non-Completion Rate

100.0%

3 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Terminated(3)
Other(2)

Detailed Status

Terminated3
unknown2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
0.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (25.0%)
N/A3 (75.0%)

Trials by Status

unknown233%
active_not_recruiting117%
terminated350%

Recent Activity

1 active trials
Showing 5 of 6
terminatednot_applicable

Noninvasive Detection and Assessment of Therapy Response in Multiple Myeloma Using Whole-Body MRI

NCT04493411
terminated

The Role of WB-MRI in the Evaluation of Prostate Cancer Patients Treated With Lutetium - Prostate Specific Membrane Antigen (Lu-PSMA)

NCT05208229
active_not_recruitingnot_applicable

Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone

NCT06321666
terminatedphase_1

Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy

NCT03619655
unknown

Whole Body Magnetic Resonance Imaging Study

NCT04117594
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04493411Not Applicable

Noninvasive Detection and Assessment of Therapy Response in Multiple Myeloma Using Whole-Body MRI

Terminated
NCT05208229

The Role of WB-MRI in the Evaluation of Prostate Cancer Patients Treated With Lutetium - Prostate Specific Membrane Antigen (Lu-PSMA)

Terminated
NCT06321666Not Applicable

Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone

Active Not Recruiting
NCT03619655Phase 1

Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy

Terminated
NCT04117594

Whole Body Magnetic Resonance Imaging Study

Unknown
NCT03134261Not Applicable

Diagnostic Imaging of Bone Metastases in Prostate Cancer Patients

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
6